Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Eml1 loss impairs apical progenitor spindle length and soma shape in the developing cerebral cortex.

Bizzotto S, Uzquiano A, Dingli F, Ershov D, Houllier A, Arras G, Richards M, Loew D, Minc N, Croquelois A, Houdusse A, Francis F.

Sci Rep. 2017 Dec 11;7(1):17308. doi: 10.1038/s41598-017-15253-4.

2.

The transcription factor HNF-4α: a key factor of the intestinal uptake of fatty acids in mouse.

Frochot V, Alqub M, Cattin AL, Carrière V, Houllier A, Baraille F, Barbot L, Saint-Just S, Ribeiro A, Lacasa M, Cardot P, Chambaz J, Rousset M, Lacorte JM.

Am J Physiol Gastrointest Liver Physiol. 2012 Jun 1;302(11):G1253-63. doi: 10.1152/ajpgi.00329.2011. Epub 2012 Mar 29.

3.

GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice.

Ait-Omar A, Monteiro-Sepulveda M, Poitou C, Le Gall M, Cotillard A, Gilet J, Garbin K, Houllier A, Château D, Lacombe A, Veyrie N, Hugol D, Tordjman J, Magnan C, Serradas P, Clément K, Leturque A, Brot-Laroche E.

Diabetes. 2011 Oct;60(10):2598-607. doi: 10.2337/db10-1740. Epub 2011 Aug 18.

4.

Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium.

Cattin AL, Le Beyec J, Barreau F, Saint-Just S, Houllier A, Gonzalez FJ, Robine S, Pinçon-Raymond M, Cardot P, Lacasa M, Ribeiro A.

Mol Cell Biol. 2009 Dec;29(23):6294-308. doi: 10.1128/MCB.00939-09. Epub 2009 Oct 5.

5.

Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients.

Pautas E, Moreau C, Gouin-Thibault I, Golmard JL, Mahé I, Legendre C, Taillandier-Hériche E, Durand-Gasselin B, Houllier AM, Verrier P, Beaune P, Loriot MA, Siguret V.

Clin Pharmacol Ther. 2010 Jan;87(1):57-64. doi: 10.1038/clpt.2009.178. Epub 2009 Sep 30.

PMID:
19794411
6.

No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.

Pallier K, Houllier AM, Le Corre D, Cazes A, Laurent-Puig P, Blons H.

Mol Carcinog. 2009 Jul;48(7):581-5. doi: 10.1002/mc.20538.

PMID:
19353596
7.

Loss of sugar detection by GLUT2 affects glucose homeostasis in mice.

Stolarczyk E, Le Gall M, Even P, Houllier A, Serradas P, Brot-Laroche E, Leturque A.

PLoS One. 2007 Dec 12;2(12):e1288.

8.

Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

Hommais A, Rayes J, Houllier A, Obert B, Legendre P, Veyradier A, Girma JP, Ribba AS.

Thromb Haemost. 2007 Sep;98(3):593-9.

PMID:
17849048
10.

Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples.

Mahdian R, Rayes J, Girma JP, Houllier A, Obert B, Meyer D, Veyradier A.

Thromb Haemost. 2006 Jun;95(6):1049-51. No abstract available.

PMID:
16732393
11.

Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma.

Lièvre A, Blons H, Houllier AM, Laccourreye O, Brasnu D, Beaune P, Laurent-Puig P.

Br J Cancer. 2006 Mar 13;94(5):692-7.

12.

Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.

Zinzindohoué F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H, Laurent-Puig P.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):594-9.

13.

Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Zinzindohoué F, Blons H, Hans S, Loriot MA, Houllier AM, Brasnu D, Laccourreye O, Tregouet DA, Stucker I, Laurent-Puig P.

Anticancer Res. 2004 May-Jun;24(3b):2021-6.

14.

Myeloperoxidase: new polymorphisms and relation with lung cancer risk.

Chevrier I, Stücker I, Houllier AM, Cenée S, Beaune P, Laurent-Puig P, Loriot MA.

Pharmacogenetics. 2003 Dec;13(12):729-39.

PMID:
14646692
15.

Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma.

Blons H, Laccourreye O, Houllier AM, Carnot F, Brasnu D, Beaune P, Zucman-Rossi J, Laurent-Puig P.

Oncogene. 2002 Jul 25;21(32):5016-23.

16.

Generation of von Willebrand factor epitope libraries expressed in E. coli.

Jumilly AL, Houllier A, Meyer D, Girma JP, Kerbiriou-Nabias D.

Biotechniques. 2002 Feb;32(2):402, 404, 406-9.

17.

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.

Veyradier A, Obert B, Houllier A, Meyer D, Girma JP.

Blood. 2001 Sep 15;98(6):1765-72.

18.

Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.

Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C.

J Am Soc Nephrol. 2001 Jan;12(1):170-6.

19.

Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.

Tout H, Obert B, Houllier A, Fressinaud E, Rothschild C, Meyer D, Girma JP.

Thromb Haemost. 2000 Feb;83(2):274-81.

PMID:
10739386
20.

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

Cabelguenne A, Blons H, de Waziers I, Carnot F, Houllier AM, Soussi T, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P.

J Clin Oncol. 2000 Apr;18(7):1465-73.

PMID:
10735894
21.

New assay for measuring binding of platelet glycoprotein IIb/IIIa to unpurified von Willebrand factor.

Veyradier A, Jumilly AL, Ribba AS, Obert B, Houllier A, Meyer D, Girma JP.

Thromb Haemost. 1999 Jul;82(1):134-9.

PMID:
10456467
22.
23.

Assay of factor VIII antigen (VIII:CAg) in 294 haemophilia A patients by a new commercial ELISA using monoclonal antibodies.

Girma JP, Fressinaud E, Houllier A, Laurian Y, Amiral J, Meyer D.

Haemophilia. 1998 Mar;4(2):98-103.

PMID:
9873846
24.

Variant forms of the pig lutropin/choriogonadotropin receptor.

VuHai-LuuThi MT, Misrahi M, Houllier A, Jolivet A, Milgrom E.

Biochemistry. 1992 Sep 8;31(35):8377-83.

PMID:
1326331
25.

Pathways of internalization of the hCG/LH receptor: immunoelectron microscopic studies in Leydig cells and transfected L-cells.

Ghinea N, Vu Hai MT, Groyer-Picard MT, Houllier A, Schoëvaërt D, Milgrom E.

J Cell Biol. 1992 Sep;118(6):1347-58.

26.

A protein kinase C inhibitory activity is present in the human T lymphoblast cell line Jurkat.

Columelli S, Houllier AM, Pérignon JL.

Immunol Lett. 1991 Nov;30(3):297-300.

PMID:
1686872
27.

Retinoic acid inhibits the expression of cytidine deaminase linked to the differentiation of the human leukemic cell line HL-60.

Guidez F, Pérignon JL, Houllier AM, Balitrand N, Abita JP.

Leukemia. 1991 Aug;5(8):699-703.

PMID:
1886422
28.

Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor.

Vuhai-Luuthi MT, Jolivet A, Jallal B, Salesse R, Bidart JM, Houllier A, Guiochon-Mantel A, Garnier J, Milgrom E.

Endocrinology. 1990 Nov;127(5):2090-8.

PMID:
2226303
29.

Influence of adenosine deaminase inhibition on the phosphoinositide turnover in the initial stages of human T cell activation.

Buc HA, Moncion A, Hamet M, Houllier AM, Thuilier L, Perignon JL.

Eur J Immunol. 1990 Mar;20(3):611-5.

PMID:
2156710
30.

High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T-cell type origin.

Venuat AM, Soria C, Soria J, Krief P, Mirshahi M, He L, Thomaidis A, Houllier A, Billard M, Boucheix C.

Cancer. 1988 Nov 1;62(9):1952-7.

PMID:
3167807
31.

Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells.

Pérignon JL, Bories DM, Houllier AM, Thuillier L, Cartier PH.

Biochim Biophys Acta. 1987 Apr 22;928(2):130-6.

PMID:
3567226
32.

Synergistic toxicity of pyrazofurin and cytidine in cytidine deaminase deficient lymphoid cells (Raji).

Pérignon JL, Thuillier L, Hamet M, Houllier AM, Cartier PH.

Int J Immunopharmacol. 1986;8(4):427-31.

PMID:
3744641
33.

Cytidine deaminase activity of human normal and malignant lymphoid cells.

Pérignon JL, Chaléon J, Leverger G, Houllier AM, Thuillier L, Cartier PH.

Clin Chim Acta. 1985 Apr 15;147(2):67-74.

PMID:
3872745
34.

Consequences of the salvage of purine compounds on the proliferation of rat T-lymphocytes with normal or inhibited purine de novo synthesis.

Thuillier L, Perignon JL, Houllier AM, Munier A, Cartier P.

Biochim Biophys Acta. 1984 Apr 24;798(3):343-9.

PMID:
6424727
35.

A facile radio-isotopic assay for phosphoribomutase activity in human red blood cells.

Pérignon JL, Houllier AM, Cartier PH.

Clin Chim Acta. 1983 Apr 25;129(3):365-70. No abstract available.

PMID:
6303632

Supplemental Content

Loading ...
Support Center